Table 4. Association between serum hsCRP concentration and non-alcoholic fatty liver disease development in male population.
| hsCRP concentration quartiles | ||||
|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |
| 502 | 1263 | 1254 | 1285 | |
| Interquartile range of hsCRP (nmol/L) | 0-0.1 | 0.2-0.4 | 0.5-0.8 | 0.9-25.9 |
| Median of hsCRP (nmol/L) | 0.1 | 0.3 | 0.6 | 1.4 |
| HR for NAFLD development (95% CI) | ||||
| Model 1 | 1.70 (1.35-2.14) | Ref | 1.30 (1.10-1.54) | 1.54 (1.31-1.81) |
| Model 2 | 1.68 (1.33-2.12) | Ref | 1.14 (0.96-1.35) | 1.25 (1.06-1.48) |
| Model 3 | 1.63 (1.29-2.05) | Ref | 1.11 (0.93-1.31) | 1.14 (0.97-1.35) |
Model 1 is a univariate analysis for hsCRP. Model 2 is adjusted for age, body mass index, systolic blood pressure and diastolic blood pressure. Model 3 is adjusted for age, body mass index, systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglyceride, total cholesterol, creatinine, uric acid, fasting plasma glucose, blood urea nitrogen, hemoglobin, height and weight. CI: confidence incidence.